FSD Pharma Announces Launch of IBS Clinical Study

CANADA: FSD Pharma has announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic R&D partner, SciCann Therapeutics. The study is designed to test the safety and efficacy of SciCann’s proprietary “Steady Stomach” cannabidiol (CBD) combination product for the treatment of irritable bowel syndrome (IBS) patients. This study follows the previously reported efficacy Read the full article…

DOJA ​​Cannabis ​​And ​​Tokyo ​​Smoke ​​Announce ​Merger

Merger ​​creates ​​Canada’s ​​first ​​retail- ​​& ​​brand-focused ​​cannabis ​​producer Two ​​Canadian ​​cannabis ​​lifestyle ​​brands ​​join ​​forces ​​in ​​a ​​transformational ​​transaction, ​​bringing ​​together industry ​​leading ​​management ​​teams, ​​British ​​Columbia ​​curated ​​handcrafted ​​cannabis ​​production, ​​a portfolio ​​of ​​visionary ​​brands ​​and ​​a ​​growing ​​nationwide ​​retail ​​footprint. Provides ​​the ​​first ​​public ​​markets ​​investment ​​opportunity ​​focused ​​on ​​cannabis ​​retail ​​and Read the full article…